Why the study?
Cardiac involvement in systemic lupus erythematosus is typically asymptomatic, and cardiogenic shock is rare, particularly as an initial manifestation.
Systemic lupus erythematosus should be considered in young patients presenting with cardiogenic shock and cutaneous lesions, as early immunosuppressive and cardiac supportive therapy can lead to significant recovery.
Supports considering SLE in young cardiogenic shock patients with lesions; leaves open prospective validation of recovery with early therapy.
Systemic lupus erythematosus (SLE) is an autoimmune disease with multisystemic features and a variety of clinical characteristics. Typical clinical manifestations of SLE include alopecia, oral ulcers, cutaneous lesions, arthritis, renal injury, and cardiac damage. Cardiac involvement is one of the common complications of SLE, which is mostly asymptomatic with only approximately 10% of cardiac injury patients experiencing symptoms such as shortness of breath and arrhythmia. However, cardiogenic shock is rare, especially as the initial manifestation of SLE. Herein, we report a case of a 15-year-old male who presented with cardiogenic shock and was eventually diagnosed with SLE.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: